Abrams resigns as Editas CMO; plus Immunocore, Spruce, Frazier, Horama and more

Editas Medicine Inc. (NASDAQ:EDIT) disclosed in an SEC filing that Judith Abrams resigned as CMO. The gene editing company did not immediately respond to a request for comment on its succession plans for the post.

Immunocore Ltd. hired Brian

Read the full 396 word article

How to gain access

Continue reading with a
two-week free trial.